Keytruda
Product
by Merck & Co., Inc.
Keytruda is the brand name for pembrolizumab, a humanized monoclonal antibody and programmed cell death protein 1 (PD-1) immune-checkpoint inhibitor. It is used in cancer immunotherapy for many types of cancer and is administered by slow intravenous injection.
2 episodes featuring Keytruda
WSJ's Take On the Week
Biotech’s rally tests the promise of cancer breakthroughs
Investors must decide whether excitement around cancer vaccines, AI and new drug platforms reflects durable growth or inflated valuations.
Sep 13, 2026 · 32 min
The Journal.
Moderna bets cancer vaccine can outlast its COVID boom
The vaccine’s melanoma results offer patients a potential new treatment while testing whether Moderna can turn mRNA expertise into a durable business.
Aug 28, 2026 · 27 min